Engagement Letters and Resources
Identify Key Governance and ESG Issues Important to Investors
Access Your Investors' Engagement Letters Via Glass Lewis' Governance Hub.
As regulatory requirements and investor expectations grow, effective shareholder engagement is more important than ever. Glass Lewis’ investor engagement letters on Governance Hub help you identify key shareholder concerns, enabling you to craft timely and effective responses.
Key Features and Benefits
Proactively Address Concerns
Leveraging the Engagement Letters on Governance Hub allows you to proactively address concerns, helping to mitigate risks and strengthen shareholder relationships.
Understand Global Engagement Trends
Access reports detailing focus list selection, engagement themes, and case studies from our Active Stewardship Engagement Program.
Strengthen Governance and ESG Practices
Leverage engagement reports to identify peer challenges, understand areas for improvement, or showcase your company’s competitive advantages.
Market-Leading Governance Platform
Our Engagement Letters and Resources are available via our user-friendly governance platform, Governance Hub. Clients can also access our corporate governance research thought leadership, and policy guidelines through the platform.
Overview of Glass Lewis' Stewardship Solutions
Glass Lewis' Stewardship team engages with hundreds of issuers globally each year on behalf of institutional investors. Below are the engagement programs we offer.
Custom Engagement Services
Glass Lewis identifies historical issues using ESG analysis and extensive vote data,
helping investors prioritize key engagements to better align efforts with proxy voting decisions.
helping investors prioritize key engagements to better align efforts with proxy voting decisions.
Active Stewardship Engagement Services
Glass Lewis’ Active Stewardship Engagement Program enables investors to maximize their engagement efficiency and impact by signing on to our program. Our focus list of 200+ global companies cover a wide range of sectors and themes. Focus list companies are selected through a comprehensive and structured screening process of ESG data, Controversy Alerts, and AGM vote result analysis.
Related Products and Services
How Plurality Voting Allows Directors to Stay on the Board Without Majority Support
This article looks at the drivers and implications of majority-unsupported directors, with a focus on the use of plurality voting and governance practices that undermine board accountability.
How Plurality Voting Allows Directors to Stay on the Board Without Majority Support
This article looks at the drivers and implications of majority-unsupported directors, with a focus on the use of plurality voting and governance practices that undermine board accountability.
Free Float, Ownership Transparency and Governance Quality: What Indonesia’s Market Stress Revealed
This article examines recent volatility in Indonesia’s equity market following MSCI’s investability and ownership transparency concerns in early 2026. It considers broader governance implications, drawing on OECD observations regarding ownership concentration and minority shareholder influence.
Free Float, Ownership Transparency and Governance Quality: What Indonesia’s Market Stress Revealed
This article examines recent volatility in Indonesia’s equity market following MSCI’s investability and ownership transparency concerns in early 2026. It considers broader governance implications, drawing on OECD observations regarding ownership concentration and minority shareholder influence.
Stewardship in Action: Engagement Snapshots on Consumer Rights and Unethical Business Practices
This article relays how Glass Lewis’ Stewardship team engages on protecting consumer rights with a transportation technology company and on addressing unethical business with a pharmaceutical company.
Stewardship in Action: Engagement Snapshots on Consumer Rights and Unethical Business Practices
This article relays how Glass Lewis’ Stewardship team engages on protecting consumer rights with a transportation technology company and on addressing unethical business with a pharmaceutical company.